Furthermore, we described a correlation between HLA-G expression by B cells and the percentage of the HLA-G binding inhibitory receptor CD85k on NK effectors in CLL subjects, while no significant correlation between HLA-G on B cells and CD85k expression by T lymphocytes was observed. Here, LILRB4 is linked to B-cell chronic lymphocytic leukemia.